HF/Transplantation News

PHILADELPHIA — In the cardiovascular outcomes analysis of the GRADE trial, liraglutide was linked to lower risk for certain CV outcomes compared with other glucose-lowering therapies, researchers reported.

Reflecting disparities in cardiovascular care, there were nearly 800,000 excess CV deaths among Black Americans between 2000 and 2022, according to a “report card” published in the Journal of the American College of Cardiology.

HF is associated with a fourfold increased risk for death and a sixfold to ninefold increased risk for sudden cardiac death, and its direct and indirect costs are estimated to reach $69.8 billion annually in the United States by 2030.

Adults with HF who practiced weekly yoga for 1 year had greater improvements in heart health than those receiving medical management alone, according to a poster presented at the European Society of Cardiology’s Heart Failure 2024 meeting.

Teleflex and its subsidiary Arrow International issued a recall of its intra-aortic balloon catheter kits due to a manufacturing error that may cause the balloon to become overtwisted.

PHILADELPHIA — In this Healio video exclusive, Deepak L. Bhatt, MD, MPH, discusses two hot topics in cardiometabolic medicine: icosapent ethyl and sotagliflozin.

PHILADELPHIA — Early, cost-effective screening may predict and prevent incident heart failure events for patients with diabetes and no prior heart disease, a speaker reported.

Multidisciplinary experts from across cardiometabolic subspecialties will gather again to showcase the latest clinical research at the Heart in Diabetes CME Conference.

Much of the mortality in rheumatic heart disease was attributable to heart failure, and was significantly reduced by interventional treatment, which may stand as a barrier to improving mortality in lower-income countries, data show.

Return-to-play considerations and CVD risks of people who perform under life-threatening conditions were among the key sports cardiology topics at the American College of Cardiology Scientific Session in April in Atlanta.